Harenberg J, Zimmermann R, Staiger C, de Vries J X, Walter E, Weber E
Eur J Clin Pharmacol. 1982 Oct;23(4):365-7. doi: 10.1007/BF00613622.
In patients on oral warfarin, nicoumalone and phenindione an increase in the anticoagulant effect has been described during concomitant treatment with cimetidine. Therefore the effect of cimetidine on the steady state dynamics of phenprocoumon has been investigated in ten outpatients. No change in the anticoagulant effect of phenprocoumon was observed during or after two weeks on cimetidine, as measured by the thrombotest coagulation method, prothrombin time, fibrinopeptide A concentration and plasma phenprocoumon level. The data show that cimetidine does not interact with the metabolism of phenprocoumon in contrast to warfarin. Thus, phenprocoumon maintenance therapy when combined with concomitant cimetidine treatment can be considered not to carry an increased risk of haemorrhagic complications.
在口服华法林、尼可香豆素和苯茚二酮的患者中,已报道在与西咪替丁联合治疗期间抗凝作用增强。因此,在10名门诊患者中研究了西咪替丁对苯丙香豆素稳态动力学的影响。通过血栓试验凝血法、凝血酶原时间、纤维蛋白肽A浓度和血浆苯丙香豆素水平测定,在服用西咪替丁期间及之后两周,未观察到苯丙香豆素抗凝作用的变化。数据表明,与华法林不同,西咪替丁不与苯丙香豆素的代谢相互作用。因此,可以认为苯丙香豆素维持治疗与西咪替丁联合治疗时不会增加出血并发症的风险。